Assisted diagnosis of lung cancer metastasis to the bone using a bone absorption marker

Japanese Journal of Lung Cancer

Volumn 38, Issue 2, 1998, Pages 123-130

  Nakamura, Hiroyuki ^a   Kashiwabara, Kousuke ^a   Yagyu, Hisanaga ^a   Tsuchida, Fumihiro ^a   Kariya, Yoshiyuki ^a   Kiguchi, Toshio ^a   Matsuoka, Ken ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Bone metastasis; Carboxyterminal propeptide of type I procollagen (PICP); Cross linked carboxyterminal telopeptide of type I collagen (ICTP); Lung cancer

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; COLLAGEN TYPE 1; PROCOLLAGEN; TUMOR MARKER;

ARTICLE; BONE METASTASIS; DIAGNOSTIC VALUE; HUMAN; LUNG CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PROTEIN BLOOD LEVEL;

EID: 0031980343     PISSN: 03869628     EISSN: None     Source Type: Journal    
DOI: 10.2482/haigan.38.123     Document Type: Article

References (29)

1. Perez DJ, Powles TJ, Milan J, et al : Detection of breast carcinoma metastases in bone : Relative merit of X-rays and skeletal scintigraphy. Lancet ii : 613-616, 1983.
2. Smith PH, Bono A, Calais SF, et al : Some limitations of the radioisotope bone scan in patients with metastatic prostatic cancer : A subanalysis of EORTC trial 30853. The EORTC Urological Group. Cancer 66 : 1009-1016, 1990.
3. Pollen JJ, Witztum KF, Ashburn WL : The flare phenomenon on radionuclide bone scan in metastatic prostate cancer. Am J Roentgenol 142 : 773-776, 1984.
4. THE BONE 10 : 111-118, 1996.
5. Akimoto S, Akakura K, Shimazaki J : Clinical usefulness of serum carboxyterminal propeptide of type I procollagen and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer. Jpn J Clin Oncol 26 : 157-163, 1996.
6. Bouillon R, Bex M, Herck EV, et al : Influence of age, sex, and insulin on osteoblast function : Osteoblast dysfunction in diabetes mellitus. J Clin Endoclinol Metab 80 : 1194-1202, 1995.
7. Moro L, Gazzarrini C, Crivellari D, et al : Biochemical markers for detecting bone metastases in patients with breast cancer. Clin Chem 39 : 131-134, 1993.
8. Coleman RE, Houston S, James I, et al : Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone disease. Br J Cancer 65 : 766-768, 1992.
9. Pecherstorfer M, Zimmer-Roth I, Schilling T, et al : The diagnostic value of urinary pyridinium cross-links of collagen, serum total alkaline phosphatase, and urinary calcium excretion in neoplastic bone disease. J Clin Endocrinol Metab 80 : 97-103, 1995.
10. Kushida K, Takahashi M, Kawana K, et al : Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients. J Clin Endocrinol Metab 80 : 2447-2450, 1995.
11. Wenisch C, Bankl HC, Schonthal E, et al : Serum levels of the carboxy-terminal cross-linked telopeptide of type I collagen and laminin are elevated in Graves' disease but not in toxic nodular goiter. Clin Immunol Immunopathol 75 : 225-230, 1995.
12. Hakala M, Risteli L, Manelius J, et al : Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis. Ann Rheum Dis 52 : 866-869, 1993.
13. Elomaa I, Virkkunen P, Risteli L, et al : Serum concentration of the cross-linked carboxy-terminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma. Br J Cancer 66 : 337-341, 1992.
14. Risteli J, Elomaa I, Niemi S, et al : Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen : A new serum marker of bone collagen degradation. Clin Chem 39 : 635-640, 1993.
15. Joerring S, Jensen LT, Andersen GR, et al : Types I and III procollagen extension peptides in serum respond to fracture in humans. Arch Orthop Trauma Surg 111 : 265-267, 1992.
16. Li F, Iqbal J, Wassif W, et al : Carboxyterminal propeptide of type I procollagen in osteomalacia. Calcif Tissue Int 55 : 90-93, 1994.
17. Simon LS, Krane SM, Wortman PD, et al : Serum levels of type I and III procollagen fragments in Paget's disease of bone. J Clin Endocrinol Metab 58 : 110-120, 1984.
18. Hassager C, Risteli J, Risteli L, et al : Diurnal variation in serum markers of type I collagen synthesis and degradation in healthy premenopausal women. J Bone Miner Res 7 : 1307-1311, 1992.
19. Tahtela R, Tholix E : Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy and aminoterminalpropeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer. Anticancer Res 16 : 2289-2294, 1996.